Integrated Biosciences
PrivateLast Round
Series B
Aug 5, 2026
Total Funding Raised
$17.2M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Integrated Biosciences is a biotechnology company that develops next-generation therapeutics for age-related diseases by combining synthetic biology, artificial intelligence, and optogenetics.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Integrated Biosciences Comparables
Compare Integrated Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Transcripta Bio | 86% | |
| Gero | 84% | |
| Genesis Therapeutics | 82% |
Integrated Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 5, 2026 | ||||
| Seed | Oct 3, 2024 |
Integrated Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Polymath | Seed |
| Root Ventures | Seed |
| Illumina Ventures Labs | Seed |
| SH Fund | Seed |
| Conscience VC | Seed |
| Mission BioCapital | Seed |
| LifeSpan Vision Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 5, 2026
$68M round completed.
- Feb 19, 2026
Tony Wu, Co-Founder of xAI, joins the board.
Integrated Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Integrated Biosciences's valuation, stock price, and market status.
Is Integrated Biosciences a public or private company?
Integrated Biosciences is a private company.
What is the current stock price of Integrated Biosciences?
Integrated Biosciences is a private company with no public stock price. No recent secondary market data is available.
How much is Integrated Biosciences worth (valuation)?
Valuation information for Integrated Biosciences is not publicly available.
Can I buy Integrated Biosciences stock?
Integrated Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Integrated Biosciences's last funding round?
Integrated Biosciences's most recent funding round was Seed on October 3, 2024.
Who are the main investors in Integrated Biosciences?
Key investors in Integrated Biosciences include Sutter Hill Ventures.
Will Integrated Biosciences IPO soon?
No public IPO plans have been announced for Integrated Biosciences.
How can I track Integrated Biosciences secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Integrated Biosciences's secondary market activity and sign up for updates.